Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?

ABSTRACT Background: Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization. The minimum acceptable mobilized peripheral blood stem cell count to prevent deleterious effects during...

ver descrição completa

Detalhes bibliográficos
Autor principal: Crusoe,Edvan de Queiroz (author)
Outros Autores: Higashi,Fabiana (author), Martinez,Gracia Aparecida (author), Barros,José Carlos (author), Bellesso,Marcelo (author), Rossato,Marina (author), Marret,Ana Cinira F. (author), Chiattone,Carlos Sérgio (author), Hungria,Vania Tietsch de Moraes (author)
Formato: article
Idioma:eng
Publicado em: 2016
Assuntos:
Bone marrow transplantation
Multiple myeloma
Granulocyte-colony stimulating factor
Cyclophosphamide
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842016000400302
País:Brasil
Oai:oai:scielo:S1516-84842016000400302

Texto Completo

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842016000400302

Registos relacionados